677702-58-8 Usage
Uses
Used in Organic Synthesis:
5-Bromo-4-methylnicotinic acid is used as a key intermediate in the synthesis of various organic compounds. Its unique structure and reactivity make it a valuable building block for the creation of complex molecules and pharmaceuticals.
Used in Pharmaceutical Research:
5-Bromo-4-methylnicotinic acid is used as a research compound in the development of new drugs. Its properties and interactions with biological systems can provide insights into potential therapeutic applications and help in the design of novel pharmaceutical agents.
Used in Chemical Identifiers:
5-Bromo-4-methylnicotinic acid is used as a reference compound in the assignment of chemical identifiers such as PubChem CID, InChI, and SMILES. These identifiers are crucial for the accurate representation and communication of chemical structures in scientific research and databases.
Used in Safety and Handling Procedures:
5-Bromo-4-methylnicotinic acid is used as a case study in the development of safety procedures and personal protective equipment for handling potentially hazardous chemicals. Its properties and potential risks inform the creation of guidelines and protocols to ensure the safe use and disposal of such compounds in research and industrial settings.
Check Digit Verification of cas no
The CAS Registry Mumber 677702-58-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,7,7,7,0 and 2 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 677702-58:
(8*6)+(7*7)+(6*7)+(5*7)+(4*0)+(3*2)+(2*5)+(1*8)=198
198 % 10 = 8
So 677702-58-8 is a valid CAS Registry Number.
677702-58-8Relevant articles and documents
NAPHTHYRIDINES AS INHIBITORS OF HPK1
-
Paragraph 1835; 1836, (2018/10/21)
Naphthyridine compounds and their use as inhibitors of HPK1 are described. The compounds are useful in treating HPK1-dependent disorders and enhancing an immune response. Also described are methods of inhibiting HPK1, methods of treating HPK1-dependent disorders, methods for enhancing an immune response, and methods for preparing the naphthyridine compounds.
Indazolecarboxamide derivatives, preparation and use thereof as CDK1, CDK2 and CDK4 inhibitors
-
Page/Page column 20, (2008/06/13)
Compound corresponding to general formula (I): [image] in which, R1 represents a hydrogen or halogen atom, an NH2, NHR2, NHCOR2, NO2, CN, CH2NH2 and CH2NHR2; or alternatively R1 represents an optionally substituted phenyl or an optionally substituted heteroaromatic group; Ar represents an optionally substituted phenyl group or an optionally substituted heteroaromatic group; n represents 0, 1, 2 or 3; in the form of a base, of an addition salt with an acid, of a hydrate or of a solvate. Application in therapy.
